Genexine, Inc. (KOSDAQ:095700)

Genexine Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 4, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	229,218	410,353	470,211	1,459,198	3,069,933	1,485,081
Market Cap Growth	-27.48%	-12.73%	-67.78%	-52.47%	106.72%	1227.62%
Enterprise Value	-	402,586	527,984	1,478,119	3,072,402	1,489,566
Last Close Price	5040.00	9900.00	14384.62	42410.56	90422.51	45465.87
PE Ratio	-	-	-	-	111.35	-
PS Ratio	39.47	92.70	29.14	39.62	165.55	131.39
PB Ratio	0.80	1.38	1.70	2.81	5.72	5.00
P/TBV Ratio	0.80	1.39	1.74	2.86	5.78	5.08
EV/Sales Ratio	-	90.95	32.72	40.14	165.69	131.78
Debt / Equity Ratio	0.24	0.23	0.30	0.10	0.05	0.13
Asset Turnover	0.01	0.01	0.03	0.06	0.04	-
Quick Ratio	1.05	1.41	0.42	0.51	0.37	3.82
Current Ratio	1.29	1.69	0.66	0.74	0.51	4.23
Return on Equity (ROE)	-17.31%	-23.28%	-14.26%	-9.26%	6.61%	-
Return on Assets (ROA)	-6.70%	-6.85%	-4.11%	-1.93%	-5.12%	-
Return on Capital (ROIC)	-6.98%	-7.22%	-4.51%	-2.10%	-5.44%	-
Return on Capital Employed (ROCE)	-13.80%	-13.00%	-10.90%	-3.30%	-7.00%	-13.30%
Earnings Yield	-23.79%	-16.30%	-11.90%	-3.29%	0.90%	-1.11%
FCF Yield	-18.46%	-11.05%	-15.22%	-4.74%	-1.46%	-3.07%
Buyback Yield / Dilution	-21.23%	-24.01%	-0.73%	-2.14%	-14.41%	-103.15%

Updated May 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.